Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment also designs, develops, and markets a portfolio of motion …
Over the last 12 months, insiders at Orthofix Medical Inc. have bought $0 and sold $464 worth of Orthofix Medical Inc. stock.
On average, over the past 5 years, insiders at Orthofix Medical Inc. have bought $398,117 and sold $186,685 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 7,500 shares for transaction amount of $101,025 was made by Hinrichs James F. (director) on 2023‑09‑14.
2024-12-17 | Sale | CAO | 26 <0.0001% | $17.84 | $464 | -2.79% | ||
2023-09-14 | director | 7,500 0.0209% | $13.47 | $101,025 | +2.62% | |||
2023-05-26 | Sale | President of Global Spine | 3,876 0.0109% | $19.00 | $73,644 | -26.41% | ||
2023-05-24 | Sale | President of Global Spine | 4,367 0.0124% | $19.00 | $82,973 | -26.13% | ||
2023-03-10 | Sale | director | 4,262 0.012% | $17.75 | $75,651 | -12.41% | ||
2021-11-22 | director | 2,000 0.0098% | $31.15 | $62,300 | -15.70% | |||
2021-11-19 | CFO | 1,400 0.0069% | $30.05 | $42,070 | -12.36% | |||
2021-11-19 | director | 1,660 0.0082% | $30.27 | $50,248 | -12.36% | |||
2021-11-18 | CEO | 1,670 0.0088% | $31.14 | $52,004 | -9.28% | |||
2021-11-18 | Chief Legal & Develop. Officer | 1,000 0.0051% | $30.34 | $30,340 | -9.28% | |||
2020-06-05 | Sale | Chief Strategy Officer | 8,750 0.0454% | $37.41 | $327,323 | +1.54% | ||
2020-03-16 | director | 20,000 0.1056% | $24.25 | $485,000 | +41.92% | |||
2020-03-12 | director | 10,000 0.052% | $26.85 | $268,469 | +26.12% | |||
2020-02-27 | CEO | 2,900 0.015% | $35.48 | $102,895 | -6.27% | |||
2019-10-31 | director | 20,000 0.1064% | $42.27 | $845,305 | -19.47% | |||
2019-08-28 | Sale | CEO | 5,805 0.0307% | $50.97 | $295,874 | -28.03% | ||
2019-06-13 | Sale | CEO | 17,780 0.0937% | $51.11 | $908,654 | -11.87% | ||
2019-05-14 | Sale | CEO | 21,336 0.113% | $53.71 | $1.15M | -13.57% | ||
2019-04-17 | Sale | CEO | 11,898 0.0627% | $52.35 | $622,888 | -5.87% | ||
2019-02-19 | Sale | President, Global Extremities | 48,398 0.2562% | $65.00 | $3.15M | -21.76% |
Mason Brad | CEO | 165041 0.4319% | $17.45 | 1 | 16 | <0.0001% |
GERO JAMES | director | 156630 0.4099% | $17.45 | 9 | 0 | <0.0001% |
MATRICARIA RONALD A | director | 154939 0.4054% | $17.45 | 5 | 0 | +12.76% |
Serbousek Jon Carl | CEO | 112812 0.2952% | $17.45 | 2 | 0 | <0.0001% |
Hinrichs James F. | director | 86153 0.2254% | $17.45 | 3 | 0 | +20.2% |
Armistice Capital Llc | $53.72M | 9.86 | 3.7M | +2.78% | +$1.45M | 0.17 | |
Helm Capital Management LLC | $53.22M | 9.77 | 3.67M | 0% | +$0 | 1.57 | |
BlackRock | $47.82M | 8.78 | 3.29M | -0.73% | -$349,772.28 | <0.01 | |
Engine Capital Management Lp | $44.07M | 8.09 | 3.04M | 0% | +$0 | 8.9 | |
Morgan Stanley | $40.07M | 7.35 | 2.76M | +31.86% | +$9.68M | <0.01 |